Similar articles

• Macrophages in Hodgkin's lymphoma.

  Pazianas M. Pazianas M. N Engl J Med. 2010 Jun 3;362(22):2135; author reply 2136. N Engl J Med. 2010. PMID: 20527079 No abstract available.
• A breakthrough in Hodgkin's disease.

  DeVita VT Jr. DeVita VT Jr. Nat Rev Clin Oncol. 2010 Apr;7(4):179. doi: 10.1038/nrclinonc.2010.36. Nat Rev Clin Oncol. 2010. PMID: 20354537 No abstract available.
• Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

  Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Jaffe ES, Lenz G, Connors JM, Staudt LM, Chan WC, Gascoyne RD. Steidl C, et al. N Engl J Med. 2010 Mar 11;362(10):875-85. doi: 10.1056/NEJMoa0905680. N Engl J Med. 2010. PMID: 20220182 Free PMC article.
• Advances in biology, diagnostics, and treatment of Hodgkin's disease.

  Küppers R, Yahalom J, Josting A. Küppers R, et al. Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):66-76. doi: 10.1016/j.bbmt.2005.10.016. Biol Blood Marrow Transplant. 2006. PMID: 16399588 Review.
• Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.

  Siebert JD, McClure SP, Banks PM, Gulley ML. Siebert JD, et al. Arch Pathol Lab Med. 1995 May;119(5):474-9. Arch Pathol Lab Med. 1995. PMID: 7538289 Review.